Research Article

Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients

Table 1

Demographic and clinical characteristics of patients according to study group.

CharacteristicsTotal Low-Klotho
Klotho < 309 pg/mL
Middle-Klotho
309 ≤ Klotho < 449 pg/mL
High-Klotho
449 pg/mL ≤ Klotho
value

Number63143514
Age (year)64.2 ± 13.066.1 ± 11.963.8 ± 13.763.0 ± 13.00.80
Male gender (%)50.842.954.350.00.77
BMI (kg/m2) 21.3 ± 3.220.3 ± 3.021.8 ± 3.220.9 ± 3.20.29
Diabetes mellitus (%)33.342.937.114.30.18
Duration of dialysis (year)6.7 ± 5.46.2 ± 4.06.5 ± 5.27.6 ± 7.10.77
History of cardiovascular disease (%)12.77.111.421.40.52
Smoking (%)62.964.358.871.40.70
Serum creatinine10.6 ± 2.89.9 ± 0.910.7 ± 2.810.9 ± 0.80.63
(per week)1.36 ± 0.281.47 ± 231.33 ± 0.281.31 ± 0.290.23
nPCR (g/kg/day)0.95 ± 0.180.97 ± 130.94 ± 0.200.94 ± 0.170.91
Cardiothoracic ratio (%)50.0 ± 5.350.8 ± 6.549.5 ± 4.850.1 ± 5.60.79
Systolic blood pressure (mmHg)154.1 ± 20.0150.9 ± 20.4156.3 ± 21.7151.9 ± 15.50.63
Hemoglobin (g/dL)9.7 ± 1.39.5 ± 1.29.8 ± 1.49.5 ± 1.20.64
Serum albumin (g/dL)3.74 ± 0.363.61 ± 0.393.76 ± 0.343.84 ± 0.390.23
Total cholesterol (mg/dL)158 ± 1.3153 ± 32165 ± 36143 ± 0.350.12
Serum calcium (mg/dL)8.9 ± 0.28.6 ± 1.39.0 ± 1.28.9 ± 1.30.60
Serum phosphorus (mg/dL) 5.0 ± 0.24.6 ± 1.24.9 ± 1.45.6 ± 1.00.11
Intact PTH (pg/mL)99 (45–250)96 (47–210)94 (42–250)185 (79–298)0.35
Klotho (pg/mL)371 (309–449)245 (220–283)371 (341–401)550 (468–692)<0.0001
Serum FGF23 (pg/mL)4511 (1184–15134)2115 (609–4422)4844 (779–17492)9036 (2815–21678)0.02
1,25(OH)2D (pg/mL)8.6 ± 4.47.7 ± 3.68.4 ± 4.59.7 ± 4.90.46
Vitamin D sterols (%)46.050.048.635.70.67
Phosphate binders (%)93.710088.61000.09
ESA (%)91.910088.292.90.23
ARBs/ACEIs (%)47.621.448.671.40.03
CCBs (%)50.842.951.457.10.75
Statin (%)9.5011.414.30.20

Variables are presented as numbers of patients (percentage), as mean ± SD, or as median (interquartile range), as appropriate. Klotho: serum soluble Klotho; BMI: body mass index; nPCR: normalized protein catabolism rate; PTH: parathyroid hormone; FGF23: fibroblast growth factor 23; ESA: erythropoiesis stimulating agent; ARBs: angiotensin receptor blockers; ACEIs: angiotensin converting enzyme inhibitors; CCBs: calcium channel blockers.